Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis

被引：0
|
作者：
Sarah Kehr
Philipp Berg
Susanne Müller
Sarah A. Fiedler
Britta Meyer
Gabriele Ruppert-Seipp
Cornelia Witzenhausen
Marc E. Wolf
Hans H. Henkes
Doris Oberle
Brigitte Keller-Stanislawski
Markus B. Funk
机构：
[1] Division Safety of Medicinal Products and Medical Devices,Paul
[2] Klinikum Stuttgart,Ehrlich
[3] Department of Neuroradiology Klinikum Stuttgart,Institut (Federal Institute for Vaccines and Biomedicines)
来源：
npj Vaccines | / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We present the long-term outcomes of 44 patients who developed cerebral venous sinus thrombosis after vaccination with the adenoviral vector ChAdOx1 nCoV-19 COVID-19 vaccine. Assessment of the Extended Glasgow Outcome Scale was performed within 3–6 months after the initial hospital admissions. Patient outcomes ranged from good recovery (13 patients, 29.6%) to moderate disability (11 patients, 25.0%) and severe disability or vegetative state (6 patients, 13.6%). Fatal outcomes were reported in 14 patients (31.8%).
引用
收藏
相关论文
共 50 条
  • [31] Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis A Review
    Rizk, John G.
    Gupta, Aashish
    Sardar, Partha
    Henry, Brandon Michael
    Lewin, John C.
    Lippi, Giuseppe
    Lavie, Carl J.
    JAMA CARDIOLOGY, 2021, 6 (12) : 1451 - 1460
  • [32] Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia
    Panagiota, Victoria
    Dobbelstein, Christiane
    Werwitzke, Sonja
    Ganser, Arnold
    Cooper, Nina
    Sachs, Ulrich J.
    Tiede, Andreas
    VIRUSES-BASEL, 2022, 14 (08):
  • [33] A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis
    Turi, Maria Costanza
    Spitaleri, Francesca
    Gori, Anna M.
    Parruti, Giustino
    Rogolino, Angela A.
    Albani, Alberto
    Giusti, Betti
    Agostinone, Luciano
    Cesari, Francesca
    Ranalli, Paola
    Pulini, Stefano
    Di Gioacchino, Giorgia
    Paganelli, Roberto
    Marcucci, Rossella
    BLOOD TRANSFUSION, 2021, 19 (04) : 343 - 346
  • [34] Azd-1222Cerebral venous thrombosis and vaccine-induced immune thrombotic thrombocytopenia: 3 case reports
    Reactions Weekly, 2022, 1908 (1) : 99 - 99
  • [35] AZD-1222/Immune-globulinCerebral venous sinus thrombosis, vaccine-induced immune thrombotic thrombocytopenia and lack of efficacy
    Reactions Weekly, 2024, 2013 (1) : 77 - 77
  • [36] Cerebral Venous Sinus Thrombosis and Papilledema in Vaccine-Induced Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination
    Donaldson, Laura
    Qian, Jenn
    Lutchman, Carla
    AlShafai, Laila
    Margolin, Edward
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2023, 43 (01) : E16 - E18
  • [37] Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
    Marchandot, Benjamin
    Carmona, Adrien
    Trimaille, Antonin
    Curtiaud, Anais
    Morel, Olivier
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 689 - 691
  • [38] Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
    Benjamin Marchandot
    Adrien Carmona
    Antonin Trimaille
    Anais Curtiaud
    Olivier Morel
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 689 - 691
  • [39] AZD-1222Cerebral venous thrombosis secondary to vaccine-induced immune thrombotic thrombocytopenia (VITT): case report
    Reactions Weekly, 2022, 1916 (1) : 80 - 80
  • [40] Vaccine-induced immune thrombotic thrombocytopenia
    Kanack, Adam J.
    Padmanabhan, Anand
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (03)
12345